Vitamin D Dependent Rickets Type 1A Caused by CYP27B1 Mutation
1
조회
0
다운로드
0
인용
0
참고문헌
키워드
초록
Vitamin D dependent rickets type 1A (VDDR1A) is an autosomal recessive disorder caused by mutations in CYP27B1 . Clinical findings are growth retardation, hypotonia, muscle weakness, hypocalcemic seizures, and radiological features of rickets. We aimed to present the VDDR1A case with a genetic study of CYP27B1 . The 14- month-old boy was admitted to the hospital due to a seizure. Serum calcium, phosphorus, alkaline phosphatase, parathyroid hormone (PTH), 25(OH) vitamin D, and 1,25(OH)2 vitamin D values were 5.1 mg/dL, 3.7 mg/dL, 705 IU/L, 429 pg/mL, 24.9 ng/mL, and 8.8 pg/mL, respectively. Radiological study showed cupping and fraying of the distal ulna and radius. The molecular genetic study revealed that the patient had a compound heterozygous mutation, Phe443Profs*24 and c.589+ 1G>A, in CYP27B1 . Genetic analysis of the family members presented that the mother was heterozygous for the mutation c.589+1G>A, and that the father was heterozygous for Phe443Profs*24. The patient was treated with calcium lactate and calcitriol. Until now, six Korean patients with VDDR1A have been studied. Including this case, Korean patients with VDDR1A were found to have only three different mutations in 14 alleles, indicating that the mutation in the CYP27B1 gene is homogeneous in the Korean population.
Abstract
Vitamin D dependent rickets type 1A (VDDR1A) is an autosomal recessive disorder caused by mutations in CYP27B1 . Clinical findings are growth retardation, hypotonia, muscle weakness, hypocalcemic seizures, and radiological features of rickets. We aimed to present the VDDR1A case with a genetic study of CYP27B1 . The 14- month-old boy was admitted to the hospital due to a seizure. Serum calcium, phosphorus, alkaline phosphatase, parathyroid hormone (PTH), 25(OH) vitamin D, and 1,25(OH)2 vitamin D values were 5.1 mg/dL, 3.7 mg/dL, 705 IU/L, 429 pg/mL, 24.9 ng/mL, and 8.8 pg/mL, respectively. Radiological study showed cupping and fraying of the distal ulna and radius. The molecular genetic study revealed that the patient had a compound heterozygous mutation, Phe443Profs*24 and c.589+ 1G>A, in CYP27B1 . Genetic analysis of the family members presented that the mother was heterozygous for the mutation c.589+1G>A, and that the father was heterozygous for Phe443Profs*24. The patient was treated with calcium lactate and calcitriol. Until now, six Korean patients with VDDR1A have been studied. Including this case, Korean patients with VDDR1A were found to have only three different mutations in 14 alleles, indicating that the mutation in the CYP27B1 gene is homogeneous in the Korean population.
참고문헌 (20)
- Miller WL, "Vitamin D 1α-hydroxylase", Trends Endocrinol Metab, 11, pp.315~319 (2000)
- Portale AA, "Pediatric bone", pp.583~598 (2003), Academic Press
- Portale AA, "Human 25-hydroxyvitamin D 1α-hydroxylase : cloning, mutations, and gene expression", Pediatr Nephrol, 14, pp.620~625 (2000)
- Breslau NA, "Normal and abnormal regulation of 1, 25(OH)2D synthesis", Am J Med Sci, 296, pp.417~425 (1988)
- Kumar R, "Metabolism of 1, 25-dihydroxy vitamin D3 : evidence for side-chain oxidation", Biochemistry, 15, pp.2420~2423 (1976)
- Demir K, "Novel CYB27B1 gene mutations in patients with vitamin D-dependent rickets Type 1A", PLoS One, 10, pp.e0131376~ (2015)
- Edouard T, "Short-and long-term outcome of patients with pseudo-vitamin D deficiency rickets treated with calcitriol", J Clin Endocrinol Metab, 96, pp.82~89 (2011)
- Kim CJ, "Vitamin D 1alpha-hydroxylase gene mutations in patients with 1alpha-hydroxylase deficiency", J Clin Endocrinol Metab, 92, pp.3177~3182 (2007)
- 김찬종, "Vitamin D dependent rickets type I", Clinical and Experimental Pediatrics, 54(2), pp.51~54 (2011), 대한소아청소년과학회
- Cho JH, "Long-term clinical outcome and the identification of homozygous CYP27B1gene mutations in a patient with vitamin D hydroxylation-deficient rickets type 1A", Ann Pediatr Endocrinol Metab, 21, pp.169~173 (2016)
- Kitanaka S, "No enzyme activity of 25-hydroxyvitamin D3 1α-hydroxylase gene product in pseudovitamin D deficiency rickets, including that with mild clinical manifestation", J Clin Endocrinol Metab, 84, pp.4111~4117 (1999)
- Wang JT, "Genetics of vitamin D 1α-hydroxylase deficiency in 17 families", Am J Hum Genet, 63, pp.1694~1702 (1998)
- Malloy PJ, "Genetic disorders and defects in vitamin D action", Rheum Dis Clin North Am, 38, pp.93~106 (2012)
- Fatma Dursun, "Genetic and clinical characteristics of the patients with Vitamin D Dependent Rickets Type 1A", Journal of Clinical Research in Pediatric Endocrinology (2018), Galenos Yayinevi[DOI]
- Akerstrom G, "Parathyroid glands in calcium regulation and human disease", Ann N Y Acad Sci, 1040, pp.53~58 (2005)
- Acar S, "Genetic causes of rickets", J Clin Res Pediatr Endocrinol, 9, pp.88~105 (2017)
- Wang X, "Novel gene mutations in patients with 1alpha-hydroxylase deficiency that confer partial enzyme activity in vitro", J Clin Endocrinol Metab, 87, pp.2424~2430 (2002)
- Nishikawa M, "Generation of 1, 25-dihydroxyvitamin D3 in CYP27B1 knockout mice by treatment with 25-hydroxyvitamin D3 rescued their rachitic phenotypes", J Steroid Biochem Mol Biol, 185, pp.71~79 (2019)
- Fu GK, "Cloning of human 25-hydroxyvitamin D 1 alpha-hydroxylase and mutations causing vitamin D-dependent rickets type I", Mol Endocrinol, 11, pp.1961~1970 (1997)
- Fu GK, "Complete structure of the human gene for the vitamin D 1α-hydroxylase, P450c1α", DNA Cell Biol, 16, pp.1499~1507 (1997)